Pulished Date October, 2018
ID: 534
Share on
Share on

Europe Preclinical In-vivo Imaging Market By Modality (optical Imaging, Nuclear Imaging, Micro-MRI, Micro-CT, Micro-ultrasound, Photoacoustic, And Magnetic Particle Imaging Systems), By Reagent (optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents, And CT Contrast Agents), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017-2022)

Pulished: October, 2018
ID: 534
Pages: 137

Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Modality                

                                5.1.1 Optical imaging      

                                                5.1.1.1 Bioluminescence/fluorescence imaging systems

                                                5.1.1.2 Standalone fluorescence imaging systems

                                                5.1.1.3 Optical + X-ray/optical + CT imaging systems

                                5.1.2 Nuclear imaging    

                                                5.1.2.1 Micro-PET systems (standalone PET, PET/CT, and PET/MRI)

                                                5.1.2.2 Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI)

                                                5.1.2.3 Tri-modality (PET/SPECT/CT) imaging systems

                                5.1.3 Micro-MRI               

                                5.1.4 Micro-CT  

                                5.1.5 Micro-ultrasound 

                                5.1.6 Photoacoustic        

                                5.1.7 Magnetic particle imaging systems               

                5.2 By Reagent                 

                                5.2.1 Optical imaging reagents   

                                                5.2.1.1 Bioluminescent reagents

                                                5.2.1.2 Fluorescent imaging reagents

                                5.2.2 Nuclear imaging reagents 

                                                5.2.2.1 Preclinical PET tracers

                                                5.2.2.2 Preclinical SPECT probes

                                5.2.3 MRI contrast agents            

                                5.2.4 Ultrasound contrast agents             

                                5.2.5 CT contrast agents               

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 U.K 

                                6.3 Spain             

                                6.4 Germany     

                                6.5 Italy               

                                6.6 France          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Aspect Imaging                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Biospace Lab S.A.                     

                8.3 Bruker Corporation                 

                8.4 LI-COR Biosciences                  

                8.5 Mediso Ltd.                

                8.6 MILabs B.V.                

                8.7 MR Solutions Ltd                      

                8.8 PerkinElmer               

                8.9 TriFoil Imaging                           

                8.10 FUJIFILM VisualSonics, Inc.                                

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Preclinical in-vivo imaging Market By Region, From 2016-2022 (USD Million)
  2. Europe Preclinical in-vivo imaging Market By Modality, From 2016-2022 (USD Million)
  3. Europe Preclinical Optical imaging Market By Region, From 2016-2022 (USD Million)
  4. Europe Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2016-2022 (USD Million)
  5. Europe Preclinical Standalone fluorescence imaging systems Market By Region, From 2016-2022 (USD Million)
  6. Europe Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2016-2022 (USD Million)
  7. Europe Preclinical Nuclear imaging Market By Region, From 2016-2022 (USD Million)
  8. Europe Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2016-2022 (USD Million)
  9. Europe Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2016-2022 (USD Million)
  10. Europe Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2016-2022 (USD Million)
  11. Europe Preclinical Micro-MRI Market By Region, From 2016-2022 (USD Million)
  12. Europe Preclinical Micro-CT Market By Region, From 2016-2022 (USD Million)
  13. Europe Preclinical Micro-ultrasound Market By Region, From 2016-2022 (USD Million)
  14. Europe Preclinical Photoacoustic Market By Region, From 2016-2022 (USD Million)
  15. Europe Preclinical Magnetic particle imaging systems Market By Region, From 2016-2022 (USD Million)
  16. Europe Preclinical in-vivo imaging Market By Reagent, From 2016-2022 (USD Million)
  17. Europe Preclinical Optical imaging reagents Market By Region, From 2016-2022 (USD Million)
  18. Europe Preclinical Bioluminescent reagents Market By Region, From 2016-2022 (USD Million)
  19. Europe Preclinical Fluorescent imaging reagents Market By Region, From 2016-2022 (USD Million)
  20. Europe Preclinical Nuclear imaging reagents Market By Region, From 2016-2022 (USD Million)
  21. Europe Preclinical PET tracers Market By Region, From 2016-2022 (USD Million)
  22. Europe Preclinical SPECT probes Market By Region, From 2016-2022 (USD Million)
  23. Europe Preclinical MRI contrast agents Market By Region, From 2016-2022 (USD Million)
  24. Europe Preclinical Ultrasound contrast agents Market By Region, From 2016-2022 (USD Million)
  25. Europe Preclinical CT contrast agents Market By Region, From 2016-2022 (USD Million)
  26. U.K Preclinical in-vivo imaging Market By Modality, From 2016-2022 (USD Million)
  27. U.K Preclinical Optical Imaging Market By Optical imaging, From 2016-2022 (USD Million)
  28. U.K Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2022 (USD Million)
  29. U.K Preclinical in-vivo imaging Market By Reagent, From 2016-2022 (USD Million)
  30. U.K Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2022 (USD Million)
  31. U.K Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2022 (USD Million)
  32. Spain Preclinical in-vivo imaging Market By Modality, From 2016-2022 (USD Million)
  33. Spain Preclinical Optical Imaging Market By Optical imaging, From 2016-2022 (USD Million)
  34. Spain Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2022 (USD Million)
  35. Spain Preclinical in-vivo imaging Market By Reagent, From 2016-2022 (USD Million)
  36. Spain Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2022 (USD Million)
  37. Spain Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2022 (USD Million)
  38. Germany Preclinical in-vivo imaging Market By Modality, From 2016-2022 (USD Million)
  39. Germany Preclinical Optical Imaging Market By Optical imaging, From 2016-2022 (USD Million)
  40. Germany Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2022 (USD Million)
  41. Germany Preclinical in-vivo imaging Market By Reagent, From 2016-2022 (USD Million)
  42. Germany Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2022 (USD Million)
  43. Germany Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2022 (USD Million)
  44. Italy Preclinical in-vivo imaging Market By Modality, From 2016-2022 (USD Million)
  45. Italy Preclinical Optical Imaging Market By Optical imaging, From 2016-2022 (USD Million)
  46. Italy Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2022 (USD Million)
  47. Italy Preclinical in-vivo imaging Market By Reagent, From 2016-2022 (USD Million)
  48. Italy Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2022 (USD Million)
  49. Italy Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2022 (USD Million)
  50. France Preclinical in-vivo imaging Market By Modality, From 2016-2022 (USD Million)
  51. France Preclinical Optical Imaging Market By Optical imaging, From 2016-2022 (USD Million)
  52. France Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2022 (USD Million)
  53. France Preclinical in-vivo imaging Market By Reagent, From 2016-2022 (USD Million)
  54. France Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2022 (USD Million)
  55. France Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2022 (USD Million)

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients

Research Areas